KLP Kapitalforvaltning’s Xenon Pharmaceuticals XENE Stock Holding History

KLP Kapitalforvaltning’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	18,400 +800	+5%	+$44.4K	﹤0.01%	1076
2026 Q1	$1.02M	Buy	17,600 +5,300	+43%	+$244K	﹤0.01%	1018
2025 Q4	$551K	Sell	12,300 -500	-4%	-$21K	﹤0.01%	1366
2025 Q3	$514K	Hold	12,800	–	–	﹤0.01%	1379
2025 Q2	$401K	Hold	12,800	–	–	﹤0.01%	1469
2025 Q1	$429K	Hold	12,800	–	–	﹤0.01%	1382
2024 Q4	$502K	Buy	+12,800	New	+$529K	﹤0.01%	1384

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

KLP Kapitalforvaltning's XENE Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Xenon Pharmaceuticals (XENE) stake by 4.5% in Q2 2026, buying an estimated $44.4K and bringing the position to 18,400 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

KLP Kapitalforvaltning first reported a position in XENE in Q4 2024 and has held it in 7 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

KLP Kapitalforvaltning held 18,400 shares of Xenon Pharmaceuticals worth $1.11M as of Q2 2026.
KLP Kapitalforvaltning bought 800 Xenon Pharmaceuticals shares in Q2 2026, an estimated $44.4K.
Xenon Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1076 holding.
KLP Kapitalforvaltning first reported a position in Xenon Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.